Pros and cons of weight-loss jabs
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the pounds – especially among the rich and famous. So many of the UK's wealthy now get the jabs on private prescription,
The Big Question: should weight-loss injections face tougher restrictions?
Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some patients taking weight-loss drugs lose muscle at far faster rates than those relying on diet or exercise.
Everything you need to know about weight loss jabs such as Wegovy as chemists demand clampdown
Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them
Pharmacies require stricter weight-loss jab checks
Online pharmacies will now have to employ stricter checks to stop people who are already a healthy weight or have a history of eating disorders buying weight-loss jabs. They will no longer be able to dispense the medication,
Weight loss jabs: Patients in UK to face more stringent checks
People wanting to buy weight loss jabs online will face more stringent checks as part of a shake-up of UK pharmacy rules. The General Pharmaceutical Council (GPhC) has told online pharmacies they can no longer prescribe the drugs after reading a patient questionnaire,
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who fail to adhere to the new guidelines could face fitness-to-practice invest
Weight loss jabs to have tougher checks after people with eating disorders get prescriptions
Pharmacy regulator warns some people with history of eating disorders wrongly obtaining medicines such as Wegovy or Mounjaro
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.
Weight loss pill could replace injections, would be transformative for millions
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Is Compounded Semaglutide Effective for Weight Loss?
Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...
Novo Nordisk Expects Positive News on Weight-Loss Drugs, Soon, From FDA
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
Nature1d
The weight-loss drugs being tested in 2025: will they beat Ozempic?
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Novo Nordisk beats on Wegovy sales, expects slower 2025 growth
Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...
Arizona Daily Star7d
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Wegovy sales double to boost Novo Nordisk's fourth quarter as growth set to slow
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...
New Atlas22h
Ozempic is suspected in more cases of sudden vision loss
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and Wegovy develop complications with their eyesight, highlighting that we ...